STOCKHOLDERS’ EQUITY (Details) - USD ($)			1 Months Ended	3 Months Ended	12 Months Ended
	Nov. 29, 2023	Aug. 24, 2023	Aug. 31, 2024	Mar. 31, 2025	Dec. 31, 2025	Dec. 31, 2024	Aug. 23, 2024
Stockholders’ Deficit (Details) [Line Items]
Preferred stock, shares authorized (in shares)					10,000,000	10,000,000
Preferred stock, par value (in dollars per share)					$ 0.001	$ 0.001
Preferred stock, shares outstanding (in shares)					0	0
Common stock, shares authorized (in shares)					100,000,000	100,000,000
Common stock, par value (in dollars per share)					$ 0.001	$ 0.001
Shelf registration, future offering availability, amount					$ 7,500,000
Proceeds from the issuance of common stock, net					2,706,000	$ 38,000
Net proceeds received for issuance of common stock					2,706,000	38,000
Payments of stock issuance costs					$ 299,000	$ 7,000
Stock issued, warrants exercised (in shares)			505,502		40,000
Warrants issued (in shares)					5,310,676	1,036,279
Exercise price per share (in dollars per share)					$ 7.50
Net proceeds, warrants exercised					$ 10,470,000	$ 1,980,000
ATM Facility
Stockholders’ Deficit (Details) [Line Items]
Proceeds from the issuance of common stock, net					$ 3,000,000.0
Common Stock
Stockholders’ Deficit (Details) [Line Items]
Net proceeds received for issuance of common stock (in shares)					854,660	15,051
Net proceeds received for issuance of common stock					$ 1,000	$ 44,000
Stock issued, warrants exercised (in shares)				374,718	3,332,462	505,962
August 2023 Original Warrants
Stockholders’ Deficit (Details) [Line Items]
Warrants issued (in shares)		48,911
Exercise price per share (in dollars per share)		$ 86.40
Weighted average remaining life		2 years 1 month 6 days
November 2023 Original Warrants
Stockholders’ Deficit (Details) [Line Items]
Warrants issued (in shares)	456,591
Exercise price per share (in dollars per share)	$ 13.00
Weighted average remaining life	2 years 6 months
Original Warrants
Stockholders’ Deficit (Details) [Line Items]
Exercise price per share (in dollars per share)						$ 4.60	$ 2.90
Warrant exercise, gross proceeds			$ 1,100,000			$ 2,300,000
Warrant exercise, issuance cost			$ 250,000			$ 340,000
Series F-1, Series F-2 And Dealer Manager Warrants
Stockholders’ Deficit (Details) [Line Items]
Warrants issued (in shares)				1,517,608	1,036,279
Series F-2
Stockholders’ Deficit (Details) [Line Items]
Warrants issued (in shares)			122,834		0	439,686
Exercise price per share (in dollars per share)					$ 4.35		4.35
Weighted average remaining life			1 year
Series F-1
Stockholders’ Deficit (Details) [Line Items]
Warrants issued (in shares)			251,884		0	571,318
Exercise price per share (in dollars per share)					$ 4.35		$ 4.35
Weighted average remaining life			4 years 6 months
Series G-1
Stockholders’ Deficit (Details) [Line Items]
Stock issued, warrants exercised (in shares)					1,458,872
Warrants issued (in shares)					1,498,872	0
Exercise price per share (in dollars per share)					$ 2.90
Warrant exercise, gross proceeds					$ 4,500,000
Warrant exercise, issuance cost					$ 527,000
Common stock sold, price per share (in dollars per share)					$ 0.125
Net proceeds, warrants exercised					$ 182,000
Common Stock Warrants Issued in June 2025 Private Inducement | Maximum
Stockholders’ Deficit (Details) [Line Items]
Warrants issued (in shares)					1,531,816
Series H
Stockholders’ Deficit (Details) [Line Items]
Stock issued, warrants exercised (in shares)					1,458,872
Warrants issued (in shares)					1,458,872	0
Exercise price per share (in dollars per share)					$ 4.150
Warrant exercise, gross proceeds					$ 6,300,000
Warrant exercise, issuance cost					$ 695,000
Common stock sold, price per share (in dollars per share)					$ 0.125
Net proceeds, warrants exercised					$ 274,000
Common Stock Warrants Issued in August 2025 Private Inducement
Stockholders’ Deficit (Details) [Line Items]
Warrants issued (in shares)					2,261,252